AN2 Therapeutics
ANTX
ANTX
36 hedge funds and large institutions have $72.4M invested in AN2 Therapeutics in 2022 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 5 closing their positions.
Holders
36
Holders Change
+18
Holders Change %
+100%
% of All Funds
0.61%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
23
Increased
6
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
BlackRock
New York
|
$1.45M |
| 2 |
DM
2
Deerfield Management
New York
|
$5.55M |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$1.41M |
| 4 |
4
Citigroup
New York
|
$680K |
| 5 |
RCM
5
RA Capital Management
Boston,
Massachusetts
|
$29.1M |
